Eagle Veterinary Technology이글벳
044960 · KOSDAQ · ₩044960 · 이글벳
₩3,025 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩12B | ₩11B | ₩11B | ₩10B | ₩11B | ₩11B | ₩10B | ₩9.9B |
| Cost of sales | ₩7.8B | ₩7.1B | ₩7.4B | ₩6.9B | ₩7.2B | ₩6.9B | ₩7.1B | ₩6.6B |
| Gross profit | ₩4.4B | ₩3.9B | ₩3.7B | ₩3.5B | ₩3.8B | ₩3.8B | ₩3.2B | ₩3.3B |
| Operating income | ₩1.7B | ₩1.4B | ₩1.1B | ₩286M | ₩1.6B | ₩1.3B | ₩671M | ₩626M |
| Net income | ₩813M | ₩1.4B | ₩3.5B | −₩719M | ₩82M | ₩1.1B | ₩3.5B | −₩821M |
| Net income to shareholders | ₩813M | ₩1.4B | ₩3.5B | −₩719M | ₩82M | ₩1.1B | ₩3.5B | −₩821M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩68B | ₩65B | ₩64B | ₩61B | ₩61B | ₩62B | ₩61B | ₩60B |
| Current assets | ₩35B | ₩32B | ₩31B | ₩29B | ₩29B | ₩29B | ₩28B | ₩26B |
| Cash and equivalents | ₩6.1B | ₩5.1B | ₩4.5B | ₩3.7B | ₩4.5B | ₩4.2B | ₩2.8B | ₩2.6B |
| Total liabilities | ₩13B | ₩13B | ₩12B | ₩10B | ₩11B | ₩13B | ₩13B | ₩12B |
| Current liabilities | ₩9.6B | ₩9.5B | ₩8.6B | ₩7.9B | ₩8.7B | ₩10B | ₩10B | ₩9B |
| Borrowings | ₩5B | ₩5B | ₩5B | ₩3.8B | ₩4.2B | ₩5.2B | ₩5.2B | ₩5.7B |
| Total equity | ₩55B | ₩52B | ₩52B | ₩50B | ₩50B | ₩49B | ₩49B | ₩48B |
| Shareholders' equity | ₩55B | ₩52B | ₩52B | ₩50B | ₩50B | ₩49B | ₩49B | ₩48B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩1.5B | ₩1.1B | ₩2.8B | −₩572M | ₩1.5B | ₩1.8B | ₩2.5B | ₩508M |
| Free cash flow | ₩1.5B | ₩1.1B | ₩2.8B | −₩572M | ₩1.5B | ₩1.8B | ₩2.5B | ₩508M |
| Dividends paid | ₩982M | ₩0 | ₩0 | ₩0 | ₩736M | ₩0 | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Eagle Veterinary Technology / 이글벳 / 044960 / KRX:044960
Source: KRX statistical information